Apr 30, 2019
(4th Quarter & FY 2019 Consolidated Results of Ajanta Pharma Limited)
Jan 30, 2019
(3rd Quarter & 9 Months, FY 2019 Consolidated Results).......
Oct 31, 2018
(2nd Quarter & Half year, FY 2019 Consolidated Results)......
Jul 31, 2018
(1st Quarter FY 2019, Consolidated Results of Ajanta Pharma Ltd)
May 02, 2018
Ajanta Pharma Ltd. a specialty pharmaceutical formulation company reported today its performance for the 4th quarter & financial year ended 31st March 2018.
Jan 28, 2018
(3rd Quarter & 9 months, FY 2018 Consolidated Results)......
Nov 21, 2017
Ajanta Pharma Limited, announces today US FDA approval and launch of Clonidine Hydrochloride Extended Release Tablets in the US Market through its wholly owned subsidiary Ajanta Pharma USA Inc.
Oct 31, 2017
(2nd Quarter & Half year, FY 2018 Consolidated Results)......
Sep 04, 2017
Ajanta Pharma Announces US FDA Approval for Entacapone Tablets
Aug 31, 2017
Ajanta Pharma Limited, announces today the launch of Eletriptan Hydrobromide Tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA Inc. It is a bioequivalent generic version of Relpax®1 Tablets.